🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

News roundup 22 May: an inflight ‘save’ and AliveCor’s KardiaMobile, rolling out the VA/Oracle EHR in ‘waves’, Fuze Health formed from LetsGetChecked/Truepill, hacking and ransomware 92% of PHI data breaches telecareaware.com/news-roundup-2… telecareaware

Our CEO, Priya Abani, has been featured in an insightful whitepaper which explores how AI is revolutionizing various aspects of healthcare—including clinical decision-making, diagnostics and imaging, remote monitoring, operations and management, as well as drug discovery and

ISHNE Meeting full house! ⁦ISHNE⁩ ⁦Vassilis Vassilikos⁩ ⁦Manlio Márquez Murillo⁩ ⁦Gary Tse⁩ ⁦Pyotr Platonov⁩

ECG Master Class. Full house. Amazing colleagues from ⁦ISHNE⁩ !!! ⁦ISE Young Community⁩

International Society of Electrocardiology (ISE) Board at the ICE Meeting in Thessaloniki It is a pleasure to serve as Past-President and Editor-in-Chief for ⁦Journal of Electrocardiology⁩ Great colleagues to learn from ⁦ISE Young Community⁩ ⁦ElectroSIAC⁩ ⁦LAHRS⁩

No, the KETO-CTA Study Did Not Upend Causal Evidence on Atherosclerotic Cardiovascular Disease. And I think John Mandrola, MD has some sympathy for the authors. medscape.com/viewarticle/no… Michael Albert, MD C. Michael Gibson MD Michael Mindrum, MD Dr. Spencer Nadolsky Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

New from John Mandrola, MD No, the KETO-CTA Study Did Not Upend Causal Evidence on Atherosclerotic Cardiovascular Disease medscape.com/viewarticle/no…

If you saw this EKG completely isolated from clinical context, how would you interpret it? hqmeded-ecg.blogspot.com/2025/05/if-you… Willy Frick

David E. Albert, M.D John Mandrola, MD Michael Albert, MD C. Michael Gibson MD Michael Mindrum, MD Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 "One final comment on the authors’ messaging. It’s been egregious and antiscientific. Their rhetoric and spin outdo some of the most hyped late-breaking trials. This was a small, noncontrolled observational study wherein the primary endpoint went the wrong way. It’s nowhere near

Dr. Spencer Nadolsky David E. Albert, M.D John Mandrola, MD Michael Albert, MD C. Michael Gibson MD Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 having followed this story for a while it's nice to hear @drjohn's fresh perspective. I agree with the "egregious" sentiment. Despite broad agreement of the KETO-CTA study's glaring failures, the researchers seem undeterred and continue with their false claims. It is unethical.

Peer review and JACC advances failed their jobs for the KETO CTA study. Hopefully they learn from their mistakes. I do not believe the keto brigade will learn. They seem to be doubling down. 🤷‍♂️ "One final comment on the authors’ messaging. It’s been egregious and

David E. Albert, M.D John Mandrola, MD Michael Albert, MD C. Michael Gibson MD Michael Mindrum, MD Dr. Spencer Nadolsky Louder for the KETO CTA “trialists” who clearly can’t hear criticisms of their study. Hype that will harm their followers, IMHO

“But what about how people gain back weight after stopping a GLP-1 medicine?” Well, what about cholesterol going up after stopping a statin? What about blood pressure going up after stopping an ACE inhibitor? What about mood worsening after stopping an SSRI? What about blood

In the KETO-CTA study, diet-induced hypercholesterolemia (LDL-C > 190 mg/dL) appeared to promote rapid plaque formation (see Image 1). H/t Dr Anna Borek As a reminder: based on well-established literature, if LDL-C had been maintained below 55 mg/dL (~1.5 mmol/L) or lower, plaque

Prof. Mina Chung, President of ⁦Heart Rhythm Society⁩ delivering the closing conference of our ⁦ISHNE⁩ meeting in Thessaloniki! Thanks Prof. Vassilikos for inviting her to our meeting!!!

Really bummed I missed National Lipid Association this year! Glad Rebecca is there representing. I also would have loved to see this!

🧪 New Phase 2 Trial: High-Dose Semaglutide (up to 16 mg/week) --- Can more sema drive more results in type 2 diabetes + obesity? Let’s break it down ⬇️ 🔍 STUDY DESIGN 🔹245 adults w/ type 2 diabetes + BMI ≥27 kg/m² 🔹All on metformin 🔹Randomized to: ◽ Semaglutide 2 mg

The vast majority of patients with #CHD have Lp(a) levels far below what is considered a typical risk-enhancing threshold, suggesting that the attributable risk from Lp(a) is more complex than previously perceived. Learn more: bit.ly/43lbEMP #JACC JACC Journals

The keto cult is one of the worst. Extremely dishonest folks.

Just when you think this nonsense can't get any worse, you find this hilarious attempt to lie about the lie: - we made a mistake and did not include the pre-registered primary endpoint when we full-well knew and then attempted to obscure the data and did not include it any of